Senator Sherwin Gatchalian on Friday urged the Bureau of Internal Revenue (BIR) and the Food and Drug Administration (FDA) to widen the list of value-added tax (VAT)-exempt medicines to help ease the financial strain on Filipino patients. “Walang Pilipino ang dapat mapagkaitan ng pagkakataong mapangalagaan ang kanilang kalusugan at makabili ng murang gamot (No Filipino should be denied the opportunity …
Read More »
The Market Monitor Minding the Nation's Business